The exosomes that are secreted under hypoxia enhance the invasiveness and stemness of prostate cancer cells by targeting adherent junction molecules and increased level of diverse signaling molecules (TGF-β2, TNFlα, IL-6, TSG101, Akt, ILK1, MMP, and β-catenin) [150]. The gene discussed is IL6; the disease is prostate carcinoma.